Anaplastic Large Cell Lymphoma Terminated Phase Trials for DB06809 (Plerixafor)

Also known as: Lymphomas, Anaplastic Large-Cell / Anaplastic large-cell lymphoma / Large cell (Ki-1+) lymphoma / Lymphoma, Large-Cell, Anaplastic / Anaplastic large cell lymphoma, CD30-positive

IndicationStatusPhase
DBCOND0028602 (Anaplastic Large Cell Lymphoma)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01408043Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin LymphomaTreatment